Registry for patients with heart failure
Registry for Longitudinal Mortality and Therapy in Patients With Heart Failure (GREARTWAL Study)
This study collects health information from people hospitalized with heart failure in China to see how they can be better treated and what factors affect their recovery.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 10500 (estimated) |
| Ages | 18 Years to 90 Years |
| Sex | All |
| Sponsor | Shanghai 10th People's Hospital Academic / other |
| Locations | 1 site (Shanghai, Shanghai Municipality) |
| Trial ID | NCT04062500 on ClinicalTrials.gov |
What this trial studies
This registry collects extensive clinical data on patients hospitalized with acute heart failure across multiple hospitals in China. It aims to investigate the clinical features, prognosis, and management of heart failure patients, focusing on identifying high-risk individuals and understanding factors that influence their outcomes. The study will also assess patient compliance, adverse drug effects, and the impact of self-management on health outcomes. By compiling this information, the registry seeks to enhance the understanding of heart failure and improve patient care.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 and older who meet established heart failure diagnostic criteria.
Not a fit: Patients under 18 years old or those with a life expectancy of less than one year due to other clinical conditions may not benefit from this study.
Why it matters
Potential benefit: If successful, this registry could lead to improved management strategies and outcomes for patients with heart failure.
How similar studies have performed: Other studies have successfully utilized registry approaches to improve understanding and management of heart failure, indicating potential for this study's success.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: \- 1. 18 years and older. 2. Meet the diagnostic criteria of China 2018 or JACC/AHA 2017 or ESC 2016 heart failure guidelines. 3\. Agree to be tested and sign an informed consent certificate. Exclusion Criteria: * 1\. Age\<18 years old. 2. Patients who refused to participate. 3. Patients may have a life expectancy of less than 1 years due to non- heart failure clinical conditions.
Where this trial is running
Shanghai, Shanghai Municipality
- Shanghai Tenth People's Hospital, Tongji University — Shanghai, Shanghai Municipality, China (Recruiting)
Study contacts
- Principal investigator: Dachun Xu, PhD — Shanghai Tenthth People's Hospital
- Study coordinator: Dachun Xu, PhD
- Email: xdc77@tongji.edu.cn
- Phone: 18917684045
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.